Voriconazole-induced periostitis in a patient with HIV treated for coccidioidomycosis meningitis

BMJ Case Rep. 2024 Jan 25;17(1):e257884. doi: 10.1136/bcr-2023-257884.

Abstract

Voriconazole-induced periostitis is a rare adverse effect in patients on long-term therapy, characterised by periosteal inflammation and associated bony pain. The accompanying lab abnormalities (elevated serum alkaline phosphatase and fluoride) and characteristic imaging findings (uptake of radionuclide tracer on nuclear bone scan) are critical for diagnosis. The disease process is thought to be secondary to excess fluoride from voriconazole which stimulates bone formation and decreases osteoclast bone resorption. Management includes stopping voriconazole and switching to another agent.

Keywords: Drugs: infectious diseases; HIV / AIDS; Meningitis; Unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / adverse effects
  • Coccidioidomycosis* / diagnosis
  • Coccidioidomycosis* / drug therapy
  • Fluorides / adverse effects
  • HIV Infections* / drug therapy
  • Humans
  • Meningitis, Fungal*
  • Periostitis* / chemically induced
  • Periostitis* / diagnostic imaging
  • Voriconazole / adverse effects

Substances

  • Voriconazole
  • Antifungal Agents
  • Fluorides